News Posts List
Diabetic women at greater risk of developing cancer
07/20/2018
Women with diabetes have an 11 percent higher chance of developing kidney cancer.
VHL substrate transcription factor ZHX2 as an oncogenic driver in clear cell renal cell carcinoma
07/20/2018
Studies show that ZHX2 could be used as a potential therapeutic target for ccRCC.
Acute Kidney Injury in Patients With Cancer
07/19/2018
Acute kidney injury (AKI) is a common complication in cancer patients and occurs in up to 30% of patients during their disease course. Multiple myeloma, leukemia/lymphoma, renal cell carcinoma, and hematopoietic stem cell transplantation are commonly associated with the development of AKI.
Germline Mutations in Cancer Susceptibility Genes in Patients With Advanced Renal Cell Carcinoma
07/19/2018
In a study reported in JAMA Oncology, Carlo et al found a high prevalence of germline mutations in cancer susceptibility genes in patients with advanced renal cell carcinoma (RCC).
Renal cell cancer risk after kidney transplantation
07/19/2018
This study shows the risk of RCC after kidney transplantation.
Only 16% of those most at risk of bladder and kidney cancer check for this one vital sign
07/19/2018
Blood in urine is a key symptom of kidney cancer.
Researchers suggest new treatment for rare inherited cancers
07/18/2018
While studying two rare inherited cancer syndromes, Yale Cancer Center (YCC) scientists have found the cancers are driven by a breakdown in how cells repair their DNA.
Magnetized wire could be used to detect cancer in people
07/17/2018
Scientists at Stanford used a magnetic wire to capture free-floating tumor cells in the blood, a technique that soon could be used in humans to yield an earlier cancer diagnosis.
BMS’ Opdivo/Yervoy combo cleared for kidney cancer
07/16/2018
Approval was based on data from the Phase III CheckMate -214 clinical trial, in which the Opdivo (nivolumab) + Yervoy (ipilimumab) combination showed “a significant and unprecedented increase in overall survival (OS) in this patient population compared to a current standard of care, sunitinib,” according to BMS.
A Call for Better Screening for Hereditary Renal Cell Carcinoma
07/13/2018
It may be time to adopt a broader approach to tumor and matched normal sequencing in patients with advanced renal cell carcinoma (RCC), according to a large new study.